Hirvonen T P, Halinen M O, Kala R A, Olkinuora J T
Department of Internal Medicine, Kuopio University Hospital, Finland.
Eur Heart J. 1998 Jun;19(6):885-92. doi: 10.1053/euhj.1997.0866.
To determine lengths and causes of pre- and in-hospital delays in thrombolytic treatment.
A prospective national survey covering 48 of the 51 Finnish university, central and general hospitals to obtain basic data before the start of a public campaign to shorten patient-related delay in acute myocardial infarction.
One thousand and twelve consecutive patients with acute myocardial infarction who received thrombolytic therapy over 3 months in 1995 and who represent 40% of all patients with confirmed acute myocardial infarction.
The median interval between onset of infarction symptoms and initiation of thrombolytic therapy was 160 min (30-647). Only 13% of the patients received thrombolysis within 60 min and 38% within 120 min. The median time from the onset of symptoms to the call for help was 60 min (5-491), and no difference was found in patients with or without a history of previous myocardial infarction (60 and 64 min, respectively). Only 52% of the patients called to the dispatch centre. The median delay from calling for help to hospital arrival was 40 min (10-170). The median in-hospital door-to-needle thrombolysis delay was 40 min (12-196). In 13% of hospitals the median delay was more than 60 min. The emergency physician encountered difficulties in decision making in 33% of cases.
Only 38% of the patient received thrombolysis within 2 h of onset of symptoms. Patient-related delay before they sought help accounted for the major portion of the total treatment delay. Thus the findings emphasize the importance of prompt action when people are confronted with an acute heart attack. Reorganizing the emergency medical service and emergency department routines is also a necessary target to shorten thrombolysis delays. The delay attributable to transporting patients could be shortened by initiating thrombolytic treatment in the pre-hospital setting. In Finnish hospitals, door-to-needle delay was acceptable in cases with clear indications for thrombolysis. However, emergency physicians often had diagnostic difficulties, which led to remarkably longer in-hospital delays.
确定溶栓治疗的院前及院内延迟时间和原因。
一项前瞻性全国性调查,涵盖芬兰51所大学医院、中心医院和综合医院中的48所,以在开展缩短急性心肌梗死患者相关延迟的公共活动开始前获取基础数据。
1995年3个月内连续接受溶栓治疗的1012例急性心肌梗死患者,占所有确诊急性心肌梗死患者的40%。
梗死症状发作至开始溶栓治疗的中位间隔时间为160分钟(30 - 647分钟)。仅13%的患者在60分钟内接受溶栓治疗,38%的患者在120分钟内接受治疗。症状发作至呼救的中位时间为60分钟(5 - 491分钟),既往有心肌梗死病史和无心肌梗死病史的患者之间未发现差异(分别为60分钟和64分钟)。仅52%的患者呼叫了调度中心。呼救至医院到达的中位延迟时间为40分钟(10 - 170分钟)。院内门到针溶栓延迟的中位时间为40分钟(12 - 196分钟)。13%的医院中位延迟时间超过60分钟。33%的病例中急诊医生在决策方面遇到困难。
仅38%的患者在症状发作2小时内接受了溶栓治疗。患者寻求帮助前的相关延迟占总治疗延迟时间的大部分。因此,研究结果强调了人们遭遇急性心脏病发作时迅速行动的重要性。重组紧急医疗服务和急诊科常规流程也是缩短溶栓延迟的必要目标。通过在院前环境中启动溶栓治疗可缩短患者转运导致的延迟。在芬兰医院,有明确溶栓指征的情况下门到针延迟是可接受的。然而,急诊医生常存在诊断困难,这导致院内延迟显著延长。